RHOT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.291400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.612000E-01
Normal-vs-Stage2
5.612400E-01
Normal-vs-Stage3
1.305700E-02
Normal-vs-Stage4
6.738200E-01
Stage1-vs-Stage2
3.832600E-01
Stage1-vs-Stage3
3.126200E-02
Stage1-vs-Stage4
6.586200E-01
Stage2-vs-Stage3
8.238400E-03
Stage2-vs-Stage4
7.487600E-01
Stage3-vs-Stage4
3.901500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.180000E-01
Normal-vs-AfricanAmerican
9.060200E-01
Normal-vs-Asian
9.936800E-01
Caucasian-vs-AfricanAmerican
4.599800E-01
Caucasian-vs-Asian
6.660800E-01
AfricanAmerican-vs-Asian
9.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.335000E-01
Normal-vs-Female
8.139200E-01
Male-vs-Female
1.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.756400E-01
Normal-vs-Age(41-60Yrs)
9.887000E-01
Normal-vs-Age(61-80Yrs)
5.077400E-01
Normal-vs-Age(81-100Yrs)
1.611150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.861000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.916800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.941170E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.436150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.990000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.336600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.493600E-02
Normal-vs-Daily Drinker
1.323170E-01
Normal-vs-Weekly Drinker
2.717000E-01
Normal-vs-Occasional Drinker
9.660200E-01
Normal-vs-Social Drinker
8.574200E-01
Non Drinker-vs-Daily Drinker
7.524000E-01
Non Drinker-vs-Weekly Drinker
4.398000E-01
Non Drinker-vs-Occasional Drinker
8.416100E-03
Non Drinker-vs-Social Drinker
5.569600E-02
Daily Drinker-vs-Weekly Drinker
6.709200E-01
Daily Drinker-vs-Occasional Drinker
1.812470E-02
Daily Drinker-vs-Social Drinker
7.662100E-02
Weekly Drinker-vs-Occasional Drinker
9.952000E-02
Weekly Drinker-vs-Social Drinker
1.362190E-01
Occasional Drinker-vs-Social Drinker
6.762000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.588640E-01
Normal-vs-Grade 2
9.653600E-02
Normal-vs-Grade 3
1.144170E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.085200E-01
Grade 1-vs-Grade 3
5.945800E-01
Grade 1-vs-Grade 4
1.588640E-01
Grade 2-vs-Grade 3
9.155600E-01
Grade 2-vs-Grade 4
9.653600E-02
Grade 3-vs-Grade 4
1.144170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.627200E-01
Normal-vs-NonDiabetic
6.685600E-01
Diabetic-vs-NonDiabetic
1.592020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.993400E-01
Normal-vs-NoPancreatitis
5.932000E-01
Pancreatitis-vs-NoPancreatitis
8.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.196200E-01
Normal-vs-N1
6.064200E-01
N0-vs-N1
9.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.680400E-01
Normal-vs-TP53-NonMutant
7.449600E-01
TP53-Mutant-vs-TP53-NonMutant
9.988000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
